These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18329249)

  • 1. Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease?
    Murata M; Fujimoto M; Matsushita T; Hamaguchi Y; Hasegawa M; Takehara K; Komura K; Sato S
    J Dermatol Sci; 2008 Jun; 50(3):240-2. PubMed ID: 18329249
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevated serum interleukin-27 levels in patients with systemic sclerosis: association with T cell, B cell and fibroblast activation.
    Yoshizaki A; Yanaba K; Iwata Y; Komura K; Ogawa A; Muroi E; Ogawa F; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    Ann Rheum Dis; 2011 Jan; 70(1):194-200. PubMed ID: 20705635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal interleukin-7 (IL7) levels and normal IL7 response to CD4 T lymphopenia in patients with multiple sclerosis and systemic sclerosis.
    Storek J; Nash RA; McSweeney PA; Furst DE; Sullivan KM
    Clin Immunol; 2006 Oct; 121(1):118-9. PubMed ID: 16844418
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical significance of serum hyaluronan levels in systemic sclerosis: association with disease severity.
    Yoshizaki A; Iwata Y; Komura K; Hara T; Ogawa F; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Rheumatol; 2008 Sep; 35(9):1825-9. PubMed ID: 18688912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical association of serum CD137 (4-1BB) levels in patients with systemic sclerosis.
    Hamaguchi Y; Hasegawa M; Matsushita T; Komura K; Takehara K; Fujimoto M
    J Dermatol Sci; 2009 Feb; 53(2):159-61. PubMed ID: 18838252
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.
    Wong CK; Lit LC; Tam LS; Li EK; Wong PT; Lam CW
    Clin Immunol; 2008 Jun; 127(3):385-93. PubMed ID: 18373953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement.
    Manetti M; Guiducci S; Ceccarelli C; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2011 Oct; 70(10):1876-8. PubMed ID: 21571732
    [No Abstract]   [Full Text] [Related]  

  • 8. The prevalence of Th17 cells in patients with gastric cancer.
    Zhang B; Rong G; Wei H; Zhang M; Bi J; Ma L; Xue X; Wei G; Liu X; Fang G
    Biochem Biophys Res Commun; 2008 Sep; 374(3):533-7. PubMed ID: 18655770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of the determination of blood serum and urinary glycosaminoglycans in systemic scleroderma].
    Fuzaĭlov OR; Astakhova TA; Guseva NG
    Ter Arkh; 1984; 56(5):45-9. PubMed ID: 6463886
    [No Abstract]   [Full Text] [Related]  

  • 11. The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype.
    Rueda B; Broen J; Torres O; Simeon C; Ortego-Centeno N; Schrijvenaars MM; Vonk MC; Fonollosa V; van den Hoogen FH; Coenen MJ; Sanchez-Román J; Aguirre-Zamorano MA; García-Portales R; Pros A; Camps MT; Gonzalez-Gay MA; Martin J; Radstake TR
    Ann Rheum Dis; 2009 Feb; 68(2):253-6. PubMed ID: 18713787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibodies to enzymes of purine metabolism as a factor of gastrointestinal tract lesions in systemic scleroderma].
    Shilova LN; Gontar' IP; Zborovskaia IA; Moskvitina OV
    Eksp Klin Gastroenterol; 2009; (1):4-7. PubMed ID: 19551958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th17 and Treg balance in systemic sclerosis.
    Khoury SJ
    Clin Immunol; 2011 Jun; 139(3):231-2. PubMed ID: 21482482
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study with radio-iodinated albumin in carriers of progressive systemic sclerosis].
    Cossermelli W; Carvalho N; Netto MP
    AMB Rev Assoc Med Bras; 1974 May; 20(5):194-6. PubMed ID: 4547096
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors of the scleroderma phenotype in fibroblasts from systemic sclerosis patients.
    Qi Q; Guo Q; Tan G; Mao Y; Tang H; Zhou C; Zeng F
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):160-8. PubMed ID: 19054252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histamine concentration, histaminase activity and the histaminopexic index in systemic progressive sclerosis].
    Drampian FS; Stepanian AV; Stepanian IA
    Zh Eksp Klin Med; 1978; 18(2):61-5. PubMed ID: 685588
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis.
    Yanaba K; Muroi E; Yoshizaki A; Hara T; Ogawa F; Shimizu K; Yozaki M; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 Sep; 36(9):1917-23. PubMed ID: 19605674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is prevalence of PBC underestimated in patients with systemic sclerosis?
    Norman GL; Bialek A; Encabo S; Butkiewicz B; Wiechowska-Kozlowska A; Brzosko M; Shums Z; Milkiewicz P
    Dig Liver Dis; 2009 Oct; 41(10):762-4. PubMed ID: 19357001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic susceptibility to systemic sclerosis from clinical aspect to genetic factor analyses.
    Granel B; Bernard F; Chevillard C
    Eur J Intern Med; 2009 May; 20(3):242-52. PubMed ID: 19393491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of soluble CD26 in patients with scleroderma.
    Tamaki Z; Kubo M; Yazawa N; Mimura Y; Ashida R; Tomita M; Tada Y; Kawashima T; Tamaki K
    J Dermatol Sci; 2008 Oct; 52(1):67-9. PubMed ID: 18595667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.